Emerging resistance to chloroquine (CQ) poses a major challenge for Plasmodium vivax malaria control, and nucleotide substitutions and copy number variation in the P. vivax multidrug resistance 1 (pvmdr-1) locus, which encodes a digestive vacuole membrane transporter, may modulate this phenotype. We describe patterns of genetic variation in pvmdr-1 alleles from Acre and Amazonas in northwestern Brazil, and compare then with those reported in other malaria-endemic regions. The pvmdr-1 mutation Y976F, which is associated with CQ resistance in Southeast Asia and Oceania, remains rare in northwestern Brazil (1.8%) and its prevalence mirrors that of CQ resistance worldwide. Gene amplification of pvmdr-1, which is associated with mefloquine resistance but increased susceptibility to CQ, remains relatively rare in northwestern Brazil (0.9%) and globally (< 4%), but became common (> 10%) in Tak Province, Thailand, possibly because of drug-mediated selection. The global database we have assembled provides a baseline for further studies of genetic variation in pvmdr-1 and drug resistance in P. vivax malaria.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516255 | PMC |
http://dx.doi.org/10.4269/ajtmh.2012.12-0094 | DOI Listing |
Clin Sci (Lond)
December 2024
Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Chronic inflammatory diseases, e.g., obesity, cardiovascular disease, and type 2 diabetes, progressively suppress the anti-inflammatory heat shock response (HSR) by impairing the synthesis of key components, perpetuating inflammation.
View Article and Find Full Text PDFNature
December 2024
State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China.
Phys Rev E
November 2024
Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois 60208, USA.
Deep learning models have achieved high performance in a wide range of applications. Recently, however, there have been increasing concerns about the fragility of many of those models to adversarial approaches and out-of-distribution inputs. A way to investigate and potentially address model fragility is to develop the ability to provide interpretability to model predictions.
View Article and Find Full Text PDFClin Gastroenterol Hepatol
December 2024
Université de Lorraine, CHRU, Inserm, INFINY Institute, NGERE, F-54000 Nancy, France.
Background & Aims: Interventional clinical trials in ASUC are characterised by substantial heterogeneity due to a lack of consensus in several key areas of trial design - this impedes clinical research efforts to identify novel therapies. The objective of this initiative was to achieve the first consensus and provide clear position statements on ASUC trial design.
Methods: A modified Delphi consensus approach was employed with a panel of twenty clinicians with international representation and expertise in ASUC trial design and delivery.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!